Journal of Medicinal Chemistry · 2007 · 53 citations · 11 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryAntiparasitic PharmacologyAntiparasitic PharmacotherapyAntiparasitic TherapyMalariaAntimalarial AgentsAntimalarial ChemotherapyAntimalarial Drug DevelopmentMalaria ProphylaxisMultidrug-resistant PathogensSuppressionTreatment Of Malaria
New 6-arylvinyl- and 6-adamantylvinyl-substituted 1,2,4-trioxanes (13a-g and 14a,b) have been prepared and evaluated for antimalarial activity against multidrug resistant Plasmodium yoelii nigeriensis in mice by both oral and intramuscular routes. While all the 6-arylvinyl-substituted trioxanes, 13a-f, showed promising activity, none of the 6-adamantylvinyl-substituted trioxanes, 13g and 14a,b, exhibited significant activity. Trioxane, 13f, the most active compound of the series, provided 100% and 80% protection to malaria-infected mice at 48 mg/kg x 4 days and 24 mg/kg x 4 days, respectively, by oral route. In this model, beta-arteether (3) provided 100% protection at 48 mg/kg x 4 days and only 20% protection at 24 mg/kg x 4 days. Trioxane 13f also showed complete suppression of parasitaemia at 10 mg/kg x 4 days by oral route in rhesus monkeys infected with P. cynomolgi. None of these trioxanes, except 13f, showed significant activity by the intramuscular route.
11
Comprehensive Medicinal Chemistry
Quantitative Structure-Activity Relationships · 1991 · 749 citations
David J. Augeri, Jeffrey A. Robl, David A. Betebenner et al. · Journal of Medicinal Chemistry · 2005 · 621 citations · Full text
Identification of an antimalarial synthetic trioxolane drug development candidate
Jonathan L. Vennerstrom, Sarah Arbe‐Barnes, Reto Brun et al. · Nature · 2004 · 617 citations
Model Structure for the Inflammatory Protein C5a
Jonathan Greer · Science · 1985 · 117 citations